Literature DB >> 6101325

Structural features of glutamine substrates for human plasma factor XIIIa (activated blood coagulation factor XIII).

J J Gorman, J E Folk.   

Abstract

The action of human plasma factor XIIIa (thrombin-activated blood coagulation factor XIII) and guinea pig liver transglutaminase on purified caseins, fibrin, the derivatized gamma chain of fibrin, and a number of synthetic glutamine peptides, and peptide derivatives is reported. There are wide variations in the properties of the individual proteins and peptides as substrates for amine incorporation by the two transglutaminases. beta-Casein and several of its derivatives are excellent substrates for factor XIIIa. However, beta-casein is a relatively poor substrate for the liver enzyme. The primary site of amine incorporation by factor XIIIa in beta-casein was identified as glutamine 167. This was accomplished by labeling with fluorescent amine followed by proteolytic digestion and identification of labeled peptides. An 11-residue peptide and a 15-residue peptide, each containing 1 glutamine residue and each modeled after the primary site of amine incorporation in beta-casein, were prepared. A 13-residue peptide modeled after the primary crosslinking site in fibrin gamma chain was also prepared. Each of these polypeptides proved to be an efficient substrate for factor XIIIa and displayed significantly better substrate properties than a number of small glutamine peptide derivatives that are good substrates for liver transglutaminase.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6101325

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Factors that govern the specificity of transglutaminase-catalysed modification of proteins and peptides.

Authors:  P J Coussons; N C Price; S M Kelly; B Smith; L Sawyer
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

2.  Identification of covalently linked trimeric and tetrameric D domains in crosslinked fibrin.

Authors:  M W Mosesson; K R Siebenlist; D L Amrani; J P DiOrio
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

Review 3.  Transglutaminases.

Authors:  L Lorand; S M Conrad
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

4.  Selective modification by transglutaminase of a glutamine side chain in the hinge region of the histidine-388----glutamine mutant of yeast phosphoglycerate kinase.

Authors:  P J Coussons; S M Kelly; N C Price; C M Johnson; B Smith; L Sawyer
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

5.  Stabilization of collagen-tailed acetylcholinesterase in muscle cells through extracellular anchorage by transglutaminase-catalyzed cross-linking.

Authors:  D Hand; D Dias; L W Haynes
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

6.  Site-specific labeling of proteins for single-molecule FRET by combining chemical and enzymatic modification.

Authors:  Marcus Jäger; Eyal Nir; Shimon Weiss
Journal:  Protein Sci       Date:  2006-02-01       Impact factor: 6.725

7.  Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII.

Authors:  Kelly Njine Mouapi; Jacob D Bell; Kerrie A Smith; Robert A S Ariëns; Helen Philippou; Muriel C Maurer
Journal:  Blood       Date:  2016-03-07       Impact factor: 22.113

8.  Transglutaminase catalyses the modification of glutamine side chains in the C-terminal region of bovine beta-lactoglobulin.

Authors:  P J Coussons; N C Price; S M Kelly; B Smith; L Sawyer
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

9.  Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases.

Authors:  Siiri E Iismaa; Sara Holman; Merridee A Wouters; Laszlo Lorand; Robert M Graham; Ahsan Husain
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

10.  Isopeptide bond formation in epidermis.

Authors:  J Kubilus; H P Baden
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.